AVITA Medical (RCEL) Gains from Investment Securities (2024 - 2025)
AVITA Medical (RCEL) posted Gains from Investment Securities of -$617000.0 for Q4 2025, down 1442.5% on a QoQ basis from -$40000.0 in Q3 2025, and down 191.68% year-over-year from $673000.0 in Q4 2024.
AVITA Medical (RCEL) Gains from Investment Securities (2024 - 2025) Analysis & Trends
AVITA Medical's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$617000.0 for Q4 2025.
- Quarterly Gains from Investment Securities fell 191.68% year-over-year to -$617000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.2 million (down 898.91% YoY) and the FY2025 annual result came in at -$2.2 million, down 898.91% from the prior year.
- Gains from Investment Securities was -$617000.0 for Q4 2025 at AVITA Medical, down from -$40000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $870000.0 in Q1 2024 and bottomed at -$2.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | AVITA Medical | 132.76 Mn | 116.42 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -617,000.00 |
| Dec 31, 2025 | -617,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -1.15 Mn |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Sep 30, 2024 | 791,000.00 |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | 870,000.00 |
| Mar 31, 2024 | 870,000.00 |